Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanoplatin + Gemcitabine in Pancreatic Cancer
NCT00910741Phase 2Completed
- Sponsor
- NanoCarrier Co., Ltd.
- Start
- May 2009
- Primary completion
- Jul 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of NK211 in pancreatic cancer (PC), sponsored by NanoCarrier Co., Ltd.. Started May 2009; status: completed.
02
Drugs
NK211
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00910741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910741.